Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensity-matched study

International Journal of Cardiology

Volumn 136, Issue 3, 2009, Pages 270-277

  Adamopoulos, Chris ^a   Pitt, Bertram ^b   Sui, Xuemei ^c   Love, Thomas E ^d   Zannad, Faiez ^e   Ahmed, Ali ^f,g  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITÉ DE LORRAINE   (France)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Heart failure; Hospitalization; Magnesium; Mortality; Propensity score

Indexed keywords

DIGITALIS; MAGNESIUM;

ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, DIASTOLIC; HOSPITALIZATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MAGNESIUM; MALE; MIDDLE AGED; MORBIDITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS;

EID: 68049113424     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.05.006     Document Type: Article

References (40)

1. Enselberg C.D., Simmons H.G., and Mintz A.A. The effects of magnesium upon cardiac arrhythmias. Am Heart J 39 (1950) 703-712
2. Burch G.E., and Giles T.D. The importance of magnesium deficiency in cardiovascular disease. Am Heart J 94 (1977) 649-657
3. Gottlieb S.S. Importance of magnesium in congestive heart failure. Am J Cardiol 63 (1989) 39G-42G
4. Sueta C.A., Patterson J.H., and Adams Jr. K.F. Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new data. Magnes Res 8 (1995) 389-401
5. Zehender M., Meinertz T., Faber T., et al., Magnesium in Cardiac Arrhythmias (MAGICA) Investigators. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. J Am Coll Cardiol 29 (1997) 1028-1034
6. Cohen N., Almoznino-Sarafian D., Zaidenstein R., et al. Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation. Heart 89 (2003) 411-416
7. Eichhorn E.J., Tandon P.K., DiBianco R., et al. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE study. J Am Coll Cardiol 21 (1993) 634-640
8. Gottlieb S.S., Baruch L., Kukin M.L., Bernstein J.L., Fisher M.L., and Packer M. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J Am Coll Cardiol 16 (1990) 827-831
9. Ralston M.A., Murnane M.R., Unverferth D.V., and Leier C.V. Serum and tissue magnesium concentrations in patients with heart failure and serious ventricular arrhythmias. Ann Intern Med 113 (1990) 841-846
10. The Digitalis Investigation Group. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Control Clin Trials 17 (1996) 77-97
11. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
12. Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., and Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289 (2003) 871-878
13. Rosenbaum P.R., and Rubin D.B. The central role of propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
14. Rosenbaum P.R., and Rubin D.B. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79 (1984) 516-524
15. Rubin D.B. Using propensity score to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol 2 (2001) 169-188
16. Rubin D.B. On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 13 (2004) 855-857
17. Austin P.C., Grootendorst P., and Anderson G.M. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 26 (2007) 734-753
18. Ahmed A. A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol 99 (2007) 549-553
19. Ahmed A., Husain A., Love T.E., et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 27 (2006) 1431-1439
20. Ahmed A., Perry G.J., Fleg J.L., Love T.E., Goff Jr. D.C., and Kitzman D.W. Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J 152 (2006) 956-966
21. Ahmed A., Rich M.W., Sanders P.W., et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 99 (2007) 393-398
22. Ahmed A., Zannad F., Love T.E., et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28 (2007) 1334-1343
23. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
24. Normand S.T., Landrum M.B., Guadagnoli E., et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
25. Collins J.F., Howell C.L., and Horney R.A. Determination of vital status at the end of the DIG trial. Control Clin Trials 24 (2003) 726-730
26. Gorfine M., Hsu L., and Prentice R.L. Nonparametric correction for covariate measurement error in a stratified Cox model. Biostatistics 5 (2004) 75-87
27. Hess K.R. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14 (1995) 1707-1723
28. Rosenbaum P.R. Sensitivity analysis for matched case-control studies. Biometrics 47 (1991) 87-100
29. Rosenbaum P.R. Sensitivity to hidden bias. In: Rosenbaum P.R. (Ed). Observational Studies. 2 ed. (2002), Springer-Verlag, New York 110-124
30. Rothman K.J., and Greenland S. Precision and validity in epidemiological studies. In: Rothman K.J., and Greenland S. (Eds). Modern Epidemiology. 2nd ed. (1998), Lippincott - Raven, Philadelphia 115-134
31. Wester P.O. Electrolyte balance in heart failure and the role for magnesium ions. Am J Cardiol 70 (1992) 44C-49C
32. Ceremuzynski L., Gebalska J., Wolk R., and Makowska E. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. J Intern Med 247 (2000) 78-86
33. Valiathan S.M., and Kartha C.C. Endomyocardial fibrosis - the possible connection with myocardial levels of magnesium and cerium. Int J Cardiol 28 (1990) 1-5
34. Shechter M., Merz C.N., Paul-Labrador M., et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol 84 (1999) 152-156
35. Horton R., and Biglieri E.G. Effect of aldosterone on the metabolism of magnesium. J Clin Endocrinol Metab 22 (1962) 1187-1192
36. Eshaghian S., Horwich T.B., and Fonarow G.C. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 97 (2006) 1759-1764
37. Kroenke K., Wood D.R., and Hanley J.F. The value of serum magnesium determination in hypertensive patients receiving diuretics. Arch Intern Med 147 (1987) 1553-1556
38. Whang R. Magnesium and potassium interrelationships in cardiac arrhythmias. Magnesium 5 (1986) 127-133
39. Whang R., Oei T.O., Aikawa J.K., et al. Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia. Arch Intern Med 144 (1984) 1794-1796
40. Pitt B., Zannad F., Remme W.J., et al., Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717